Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe ARDS”

311 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 311 results

Testing effectiveness (Phase 2)UnknownNCT04715360
What this trial is testing

Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy

Who this might be right for
Covid19Sars-CoV-2 InfectionARDS, Human+1 more
Hayandra Peduli Foundation 30
Not applicableLooking for participantsNCT07176624
What this trial is testing

The PRE-VAIL Study

Who this might be right for
ARDS (Moderate or Severe)Prone PositionEnteral Nutrition Feeding+1 more
The First Hospital of Jilin University 259
Not applicableStudy completedNCT04402879
What this trial is testing

CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19Acute Respiratory Distress Syndrome+2 more
University of Calgary 596
Not applicableNot Yet RecruitingNCT06958770
What this trial is testing

Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes

Who this might be right for
ARDS (Moderate or Severe)
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Large-scale testing (Phase 3)Ended earlyNCT04012073
What this trial is testing

Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome

Who this might be right for
Respiratory Distress Syndrome, Adult
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 18
Testing effectiveness (Phase 2)UnknownNCT02112500
What this trial is testing

Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure

Who this might be right for
Respiratory Distress Syndrome, Adult
Asan Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT04569877
What this trial is testing

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia

Who this might be right for
Severe Acute Respiratory Syndrome (SARS) PneumoniaCOVID-19 Pneumonia
University of Giessen 63
Testing effectiveness (Phase 2)Study completedNCT03567577
What this trial is testing

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

Who this might be right for
ARDS
Apeptico Forschung und Entwicklung GmbH 92
Not applicableStudy completedNCT04973488
What this trial is testing

Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionAcute Respiratory Failure+1 more
Novacescu Alexandru 38
Not applicableStudy completedNCT04468035
What this trial is testing

Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation

Who this might be right for
Covid19
Fondation Hôpital Saint-Joseph 22
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Large-scale testing (Phase 3)UnknownNCT05182515
What this trial is testing

Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies

Who this might be right for
COVID-19
Centre Hospitalier St Anne 50
Not applicableLooking for participantsNCT05717218
What this trial is testing

Ultra-protective Ventilation Monitored by Electrical Impedance Tomography in Patients With Severe Acute Respiratory Distress Syndrome on Veno-venous ECMO

Who this might be right for
Severe ARDS
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Study completedNCT04326920
What this trial is testing

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Who this might be right for
COVID-19
University Hospital, Ghent 87
Large-scale testing (Phase 3)Ended earlyNCT04371393
What this trial is testing

MSCs in COVID-19 ARDS

Who this might be right for
Mesenchymal Stromal CellsRemestemcel-LAcute Respiratory Distress Syndrome+1 more
Icahn School of Medicine at Mount Sinai 223
Very early researchLooking for participantsNCT07558538
What this trial is testing

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital 24
Not applicableStudy completedNCT04926428
What this trial is testing

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

Who this might be right for
COVID-19
Grupo Mexicano para el Estudio de la Medicina Intensiva 15
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Load More Results